Translational Medicine : Citations & Metrics Report
Articles published in Translational Medicine have been cited by esteemed scholars and scientists all around the world. Translational Medicine has got h-index 15, which means every article in Translational Medicine has got 15 average citations.
Following are the list of articles that have cited the articles published in Translational Medicine.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
32 | 33 | 30 | 30 | 20 | 3 | 4 | 7 | 34 | 22 | 27 | 23 | 32 | 8 |
Research, Review articles and Editorials |
10 | 10 | 12 | 15 | 18 | 3 | 4 | 9 | 25 | 18 | 15 | 23 | 16 | 8 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
4 | 23 | 16 | 14 | 1 | 0 | 0 | 2 | 4 | 4 | 8 | 0 | 1 | 0 |
Conference proceedings |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 42 | 46 | 71 | 147 | 52 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
60 | 70 | 101 | 116 | 126 | 128 | 123 | 123 | 95 | 64 | 30 | 18 | 4 | 5 |
| Journal total citations count | 1088 |
| Journal impact factor | 5.03 |
| Journal 5 years impact factor | 12.81 |
| Journal cite score | 13.7 |
| Journal h-index | 15 |
| Journal h-index since 2019 | 12 |
Important citations (480)
Journal of critical reviews in biomedical engineering. preface |
|
Caspase-3: structure, function, and biotechnological aspects |
|
In-vitro neuroprotective effect and mechanism of 2?-hydroxy-?-cadinol against amyloid ?-induced neuronal apoptosis |
|
Resveratrol protects optic nerve head astrocytes from oxidative stress-induced cell death by preventing caspase-3 activation, tau dephosphorylation at ser 422 and formation of misfolded protein aggregates |
|
Modulation of the immune system for the treatment of glaucoma |
|
A search for mitochondrial damage in alzheimer’s disease using isolated rat brain mitochondria |
|
Caspase inhibitors: a review of recently patented compounds (2013-2015) |
|
Novel multi-marker proteomics in phenotypically matched patients with st-segment myocardial infarction: association with clinical outcomes |
|
Interleukin-1 receptor-induced pge 2 production controls acetylcholine-mediated cardiac dysfunction and mortality during scorpion envenomation |
|
Investigational drugs in phase ii clinical trials for acute coronary syndromes |
|
The deleterious role of the prostaglandin e 2 ep 3 receptor in angiotensin ii hypertension |
|
The beneficial effects of reducing nlrp3 inflammasome activation in the cardiotoxicity and the anti-cancer effects of doxorubicin |
|
Inflammation following acute myocardial infarction: multiple players, dynamic roles, and novel therapeutic opportunities |
|
Toward regeneration of the heart: bioengineering strategies for immunomodulation |
|
Association between c-reactive protein levels at hospital admission and long-term mortality in patients with acute decompensated heart failure |
|
Nlrp3 inflammasome in acute myocardial infarction |
|
Early detection biomarkers for ovarian cancer |
|
Serum proteomic study of prostate cancer with bone metastasis |
|
Review article on tumor immune microenvironment in cancer progression and cancer therapy |
|
Biochemistry apps as enabler of compound and dna computational: next-generation computing technology |
|